5. B Cell Immunotherapy: HER-Vaxx
• HER-Vaxx is a B-cell immuno-therapy designed to treat tumours that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers
• Business development discussions are ongoing
Wondering if that is just internal business discussions or with an interested BP.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-32
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.001(1.69%) |
Mkt cap ! $439.1M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.1¢ | 5.8¢ | $1.072M | 18.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 85851 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 335299 | 3 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.1¢ |
Change
0.001 ( 2.37 %) |
||||
| Open | High | Low | Volume | ||
| 5.9¢ | 6.1¢ | 5.8¢ | 7197252 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| IMU (ASX) Chart |